Cumberland Pharmaceuticals Inc.: net_income

Value{"amount": -2836128, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}
Period2025-01-01 – 2025-12-31
Statuscurrent
EntityCumberland Pharmaceuticals Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001087294-26-000020
Retrieved: 2026-08-19T10:49:05.543728+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001087294/net-income/2025-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/89728727-5162-418f-921c-1f1596297623

History